Sensys Gatso Group AB (SGGs)
CBOE 
Summary
Sensys Gatso Group AB (SGGs) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sensys Gatso Group AB ever had a stock split?
Sensys Gatso Group AB Profile
| - Industry | - Sector | Mr. Martin Dillon CEO | CBOE Exchange | SE0020356244 ISIN |
| AU Country | - Employees | - Last Dividend | 15 Jun 2023 Last Split | - IPO Date |
Overview
TruScreen Group Limited, initially known as TruScreen Limited, is a company specializing in the development, manufacture, and global sale of innovative cancer detection devices and systems. Established in 2013 and undergoing a name change in August 2020, the company has expanded its reach to various international markets including Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East, and North Africa. With its headquarters in Auckland, New Zealand, TruScreen aims to contribute significantly to early cancer detection and prevention efforts worldwide.
Products and Services
- TruScreen Cervical Cancer Screening Device
This medical device is at the forefront of TruScreen's product line, offering a cutting-edge solution for real-time identification and detection of precancerous and cancerous tissue on the cervix. Designed to enhance the effectiveness and accessibility of cervical cancer screening globally, this device aligns with the company’s mission of improving women's health outcomes.
